Browsing by Subject Drug testing

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 66  next >
Issue DateTitleAuthor(s)
25-Jan-2022A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in SpainZozaya, Néboa; Caballero, Teresa; González Quevedo, Teresa; Gamboa Setien, Pedro; González, M. Ángeles; Jódar Masanés, Ramón José; Poveda Andrés, José Luis; Guillén Navarro, Encarna; Rivero Cuadrado, Agustín; Hidalgo Vega, Álvaro
10-Aug-2015A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in PregnancyTagbor, Harry; Cairns, Matthew; Bojang, Kalifa; Coulibaly, Sheikh; Kayentao, Kassoum; Williams, John; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa; Djimdé, Moussa; Guirou, Etienne; Awine, Timothy; Quaye, Stephen L.; Njie, Fanta; Ordi i Majà, Jaume; Doumbo, Ogobara; Hodgson, Abraham; Oduro, Abraham; Meshnick, Steven R.; Taylor, Steve; Magnussen, Pascal; Ter Kuile, Feiko O.; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian
5-Feb-2021A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: a structured summary of a study protocol for a randomised controlled trialMoreno González, Gabriel; Mussetti, Alberto; Albasanz Puig, Adaia; Salvador, I.; Sureda, Anna; Gudiol González, Carlota; Salazar Soler, Ramón; Marin, M.; Garcia, M.; Navarro, V.; de la Haba Vaca, I.; Coma, E.; Sanz-Linares, G.; Dura, X.; Fontanals Martínez, Sandra; Serrano, G.; Cruz, C.; Máñez Mendiluce, Rafael
11-Jun-2015A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.Vannucchi, Alessandro M.; Kantarjian, Hagop M.; Kiladjian, Jean-Jacques; Gotlib, Jason; Cervantes Requena, F.; Mesa, Ruben A.; Sarlis, Nicholas J.; Peng, Wei; Sandor, Victor; Gopalakrishna, Prashanth; Hmissi, Abdel; Stalbovskaya, Viktoriya; Gupta, Vikas; Harrison, Claire N.; Verstovsek, Srdan; García Pagán, Juan Carlos
1991Alternativas en el tratamiento de los procesos algico-inflamatoriosBeltrán Ruiz, J. Ignasi
28-Dec-2022Antimetastatic properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in melanomaEspona Fiedler, Margarita; Manuel-Manresa, Pilar; Benítez-García, Cristina; Fontova, Pere; Quesada, Roberto; Soto Cerrato, Vanessa; Pérez Tomás, Ricardo E.
20-Jan-2009Availability and safety use of drugs in vulnerable populations:the case of pregnant woman in developing countriesSevene, Esperança Júlia Pires
23-Jun-2016Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in BovinesMestorino, Nora; Marchetti, María Laura; Lucas, Mariana Florencia; Modamio Charles, Pilar; Zeinsteger, Pedro; Fernández Lastra, Cecilia; Segarra, Ignacio; Mariño Hernández, Eduardo L.
6-Oct-2015Body-on-a-chip: Multi-Organ in vitro TOX models for preclinical and clinical drug testing, among other applications (Seminaris Tecnològics 2015)Oleaga Sancho, Carlota; Hickman, J.J.
11-Oct-2021Can the Addition of Maintenance Electroconvulsive Therapy to Pharmacotherapy Improve Relapse Prevention in Severe Major Depressive Disorder? A Randomized Controlled TrialMartínez Amorós, Erika; Cardoner, N. (Narcís); Gálvez, Verònica; Arriba Arnau, Aida de; Soria, Virginia; Palao Vidal, Diego J.; Menchón Magriñá, José Manuel; Urretavizcaya Sarachaga, Mikel
1984Càlcul de la dosi eficaç cinquanta (DE50) mitjançant ordinadorDíez Noguera, Antoni
26-Sep-2011Changes in forced expiratory volume in 1 second over time in COPDVestbo, Jørgen; Edwards, Lisa D.; Scanlon, Paul D.; Yates, Julie C.; Agustí García-Navarro, Àlvar; Bakke, Per; Calverley, Peter M.; Celli, Bartolome R.; Coxson, Harvey O.; Crim, Courtney; Lomas, David A.; MacNee, William; Miller, Bruce E.; Silverman, Edwin K.; Tal-Singer, Ruth; Wouters, Emiel; Rennard, Stephen I.
Feb-2014Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesMesa, Ruben A.; Kiladjian, Jean-Jacques; Verstovsek, Srdan; Al-Ali, Haifa Kathrin; Gotlib, Jason; Gisslinger, Heinz; Levy, Richard; Siulnik, Andres; Gupta, Vikas; Khan, Mahmudul; DiPersio, John F.; McQuitty, Mari; Catalano, John V.; Hunter, Deborah S.; Knoops, Laurent; Deininger, Michael W.; Cervantes Requena, F.; Miller, Carole; Vannucchi, Alessandro M.; Silver, Richard T.; Barbui, Tiziano; Talpaz, Moshe; Barosi, Giovanni; Winton, Elliott F.; Mendeson, Estella; Harvey, Jimmie H.Jr.; Arcasoy, Murat O.; Hexner, Elizabeth; Lyons, Roger M.; Paquette, Ronald; Raza, Azra; Sun, William; Sandor, Victor; Kantarjian, Hagop M.; Harrison, Claire N.
27-Nov-2022Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literatureGrau, Santiago; Miró Meda, José M.; Olalla, Julián; Alcalá, Juan C.; Castro, Antonio; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos
30-Mar-2014Darapladib for preventing ischemic events in stable coronary heart diseaseWhite, Harvey D.; Held, Claes; Stewart, R.; Tarka, E.; Brown, R.; Davies, R.Y.; Budaj, Andrzej; Harrington, R.A.; Steg, P.G.; Ardissino, D.; Armstrong, Paul W.; Avezum, A.; Aylward, Philip E.; Bryce, A.; Chen, H.; Chen, M.F.; Corbalan, R.; Dalby, A.J.; Danchin, Nicolas; De Winter, R.J.; Denchev, S.; Diaz, R.; Elisaf, M.; Flather, M.; Goudev, A.R.; Granger, C.B.; Grinfeld, L.; Hochman, J.S.; Husted, S.; Kim, H.S.; Koenig, W.; Linhart, A.; Lonn, E.; López-Sendón, Jose L.; Manolis, A.J.; Mohler III, E.R.; Nicolau, José C.; Pais, P.; Parkhomenko, Alexander; Sobrino, Javier; STABILITY Investigators
16-Jul-2019Disrupció de l’homeòstasi lipídica com estratègia terapèutica en leucèmia limfoblàstica aguda -TBanús Mulet, Antònia
14-Nov-2023Drug Repurposing for Cancers With Limited Survival: Protocol for a Retrospective Cohort StudyRodríguez Molinero, Alejandro; Pérez López, Carlos; Salazar González, Jose L.; García Lerma, Esther; Álvarez García, Juan A.; Soria Morillo, Luis M.; Salas Fernández, Tomás
Jan-2022Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcomeCortés Vicente, Elena; Álvarez-Velasco, Rodrigo; Pla-Junca, Francesc; Rojas-Garcia, Ricard; Paradas, Carmen; Sevilla, Teresa; Casasnovas, Carlos; Gómez-Caravaca, María Teresa; Pardo, Julio; Ramos-Fransi, Alba; Pelayo-Negro, Ana Lara; Gutiérrez-Gutiérrez, Gerardo; Turon Sans, Janina; López de Munain, Adolfo; Guerrero Sola, Antonio; Jericó, Ivonne; Martín, María Asunción; Mendoza, María Dolores; Morís, Germán; Vélez-Gómez, Beatriz; García-Sobrino, Tania; Pascual-Goñi, Elba; Reyes-Leiva, David; Illa Sendra, Isabel; Gallardo, Eduard
24-Jun-2010Early use of TIPS in patients with cirrhosis and variceal bleedingGarcía Pagán, Juan Carlos; Caca, Karel; Bureau, Christophe; Laleman, Wim; Appenrodt, Beate; Luca, Angelo; Abraldes, Juan G.; Nevens, Frederick; Vinel, Jean Pierre; Mössner, Joachim; Bosch i Genover, Jaume
3-Dec-2020Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetesBakris, George L.; Agarwal, Rajiv; Anker, Stefan D.; Pitt, Bertram; Ruilope, L. M.; Rossing, Peter; Kolkhof, Peter; Nowack, Christina; Schloemer, Patrick; Joseph, Amer; Filippatos, Gerasimos S.; FIDELIO-DKD Investigators; Cruzado, Josep Ma.